Tweet
is there a reference for the range of N50 for a bacterial genome (5-6Mb)?- does 200kbp (N50) look ok or is it too high (as in Illumia tech note, it is mentioned that 80kbp was the best N50 for ecoli genome??
-
-
Higher is always better. More repetitive genomes, and lower-quality or shorter reads will reduce the N50, but there's no reason to reduce it intentionally. -
An N50 of 200 Kbp is better than 199 Kbp and worse than 201 Kbp. Beyond that, be careful about relying too much on N50.
High N50s can still be produced from genome assemblies which are terrible in many other ways. This is something I blogged about recently:
Less of an issue for bacterial genomes is the fact that N50 also counts unknown bases. You can have 'long' scaffolds which are the result of scaffolding errors which insert thousands of unknown bases into a sequence.
My understanding of modern bacterial genome sequencing is that people are now reducing the whole genome down to just a few contigs (sometimes just 1). For bacteria, the number of contigs in your assembly is perhaps more revealing than the N50 length.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment